Ottobock expands neuro-orthotics portfolio with Fesia Technology acquisition

Under the deal, Ottobock will inherit Fesia Technology’s portfolio of functional electrical stimulation (FES) products used in neurorehabilitation. Under the deal, Ottobock will inherit Fesia Technology’s portfolio of functional electrical stimulation (FES) products used in neurorehabilitation. The transaction is anticipated to strengthen Ottobock’s neurorehabilitation portfolio. Credit: Cineberg/Shutterstock.com Ottobock has agreed to acquire Spanish medical device company Fesia Technology in a strategic move to expand its neuro-orthotics portfolio with functional electrical stimulation (FES) products. The German medtech company’s acquisition of Fesia from a consortium of investors including Fik Advanlife and Basque Fondo De Capital Riesgo, is expected to close within the…

Source: Medical Device Network